StockNews.AI

Avanos Medical and Siemens Healthineers Collaborate to Advance Integrated Solutions for Outpatient and Interventional Pain Management

StockNews.AI • 2 days

SIEGY
High Materiality8/10

Information

ALPHARETTA, Ga., Jan. 20, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) and Siemens Healthi...

Original source

AI Summary

Avanos Medical's strategic co-marketing agreement with Siemens Healthineers aims to enhance outpatient pain management procedures using their integrated imaging and radiofrequency ablation technologies. This partnership could significantly improve clinical outcomes and operational efficiency in U.S. healthcare settings, potentially driving revenue growth for Avanos.

Sentiment Rationale

Strategic partnerships in healthcare typically lead to increased market visibility and potentially higher revenue. For example, similar partnerships have historically enhanced competitive positioning and growth metrics for companies in medical technology fields.

Trading Thesis

AVNS is likely to see bullish momentum in the coming months due to strategic partnerships.

Market-Moving

  • The partnership may lead to increased revenue from outpatient procedures.
  • Enhanced operational efficiency could attract more healthcare providers to Avanos' solutions.
  • Improved clinical outcomes may boost Avanos' market share in pain management.
  • Collaboration signifies a positive shift towards advanced outpatient care.

Key Facts

  • Avanos Medical and Siemens Healthineers announce a co-marketing agreement.
  • The partnership aims to enhance outpatient pain management procedures.
  • Siemens' imaging technology will complement Avanos' radiofrequency ablation tools.
  • Focus will be on U.S. ambulatory surgery centers and hospitals.
  • Collaboration will include joint marketing and education initiatives.

Companies Mentioned

  • Siemens Healthineers (SIEGY): The partnership enhances Avanos' technology offerings for outpatient care.

Corporate Developments

This news falls under 'Corporate Developments' as it highlights a significant partnership aimed at improving healthcare outcomes. Such collaborations are crucial for medical technology companies to expand their market reach and enhance product offerings.

Avanos Medical and Siemens Healthineers Join Forces to Enhance Pain Management Solutions

Avanos Medical, Inc. (NYSE: AVNS) has partnered with Siemens Healthineers to launch a strategic co-marketing agreement aimed at promoting outpatient and interventional pain management through a comprehensive array of imaging and radiofrequency ablation (RFA) technologies. This collaboration seeks to address the evolving needs of pain management providers as they transition towards outpatient care settings.

Meeting the Demand for Advanced Pain Management Technologies

As the landscape of pain management shifts, healthcare providers are increasingly seeking efficient and economical systems. The collaboration between AVNS and Siemens Healthineers will provide ambulatory surgery centers (ASCs), hospitals, and interventional pain practices with integrated technologies designed to improve accuracy, streamline workflows, and enhance clinical outcomes.

  • Cost-Effective Solutions: Aiming to reduce procedural costs while increasing effectiveness.
  • Enhanced Workflow: Increasing operational efficiency through complementary technologies.
  • Improvement in Patient Care: Elevating the standards of care in outpatient pain management.

Leadership Remarks on the Agreement

Dave Pacitti, CEO of Avanos Medical, emphasized the company's commitment to creating value for customers. "Collaboration with Siemens Healthineers combines our RFA expertise with leading imaging technology, helping providers work smarter and improving procedural precision," said Pacitti. This is particularly crucial for expanding access to sophisticated pain management solutions in outpatient settings.

Technological Synergy for Improved Outcomes

The partnership will leverage Siemens Healthineers’ advanced mobile C-arm systems, such as the Cios Select and Cios Flow, which offer exceptional maneuverability, reliability, and imaging capabilities. When integrated with Avanos’ technologies, these systems are poised to create a seamless operational workflow, resulting in improved patient outcomes across various procedures.

Christiana Gallagher, Head of Mobile C-Arms for North America at Siemens Healthineers, stated, "Our mobile C-arm systems are designed to enhance clinical performance and facilitate daily procedures, while Felicia Kurz, Head of Advanced Therapies for North America, added that this agreement will enable outpatient centers to enhance their operational capabilities and provide superior patient care."

Focus on the U.S. Market

The co-marketing agreement will primarily target the U.S. healthcare market. Both Avanos and Siemens Healthineers will work together to deliver education, sales training, and marketing initiatives aimed at raising awareness of the clinical and operational benefits of their combined solutions.

About Avanos Medical

Avanos Medical (NYSE: AVNS) is a forward-thinking medical technology firm headquartered in Alpharetta, Georgia. Dedicated to delivering clinically superior device solutions, Avanos addresses essential healthcare needs such as providing effective nutrition delivery from hospital to home and lowering opioid dependency while aiding patient recovery. Avanos actively develops, manufactures, and markets its outstanding brands worldwide, maintaining leadership positions across several product categories.

For more information, visit www.avanos.com and follow Avanos Medical on X (@AvanosMedical), LinkedIn, and Facebook.

Related News